NEO - NEOGENOMICS INC

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 15.77

Open

$ 15.60

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 15.44 - $ 15.84

52 Week Range

$ 11.03 - $ 21.22

Volume

601,099

Average Volume

Market Cap

1.99B

Beta (5Y Monthly)

$ 1.40

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-30-2024	03-31-2024	10-Q
2	02-20-2024	12-31-2023	10-K
3	11-06-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	02-24-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	02-25-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	10-29-2020	09-30-2020	10-Q
16	07-31-2020	06-30-2020	10-Q
17	04-29-2020	03-31-2020	10-Q
18	02-28-2020	12-31-2019	10-K
19	11-13-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	02-26-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-06-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-13-2018	12-31-2017	10-K
27	11-13-2017	09-30-2017	10-Q
28	08-07-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-14-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q
36	07-31-2015	06-30-2015	10-Q
37	05-11-2015	03-31-2015	10-Q
38	03-03-2015	12-31-2014	10-K
39	11-04-2014	09-30-2014	10-Q
40	07-29-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

NeoGenomics Earnings Analysis: Q1 Recap
05/10/2024 11:21:13

BTIG Maintains Buy on NeoGenomics, Lowers ...
05/02/2024 17:43:51

BTIG analyst Mark Massaro maintains NeoGenomics (NASDAQ:NEO) with a Buy and lowers the price target from $23 to $21.

TD Cowen Maintains Buy on NeoGenomics, Low...
05/01/2024 17:49:36

TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Buy and lowers the price target from $21 to $20.

Craig-Hallum Assumes NeoGenomics at Buy, A...
05/01/2024 17:21:04

Craig-Hallum analyst Alex Nowark assumes NeoGenomics (NASDAQ:NEO) with a Buy rating and announces Price Target of $26.

Benchmark Reiterates Buy on NeoGenomics, M...
05/01/2024 15:19:50

Benchmark analyst Bruce Jackson reiterates NeoGenomics (NASDAQ:NEO) with a Buy and maintains $18 price target.

Where NeoGenomics Stands With Analysts
04/30/2024 18:00:25

Needham Maintains Buy on NeoGenomics, Lowe...
04/30/2024 17:17:41

Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and lowers the price target from $24 to $19.

CORRECTION: NeoGenomics Ticker Is NEO
04/30/2024 16:31:03

NeoGenomics Sees Fy24 Revenue Of $650M - $...
04/30/2024 11:36:57

NeoGenomics Q1 Adj $(0.02) Beats $(0.05) E...
04/30/2024 11:34:47

NeoGenomics (NASDAQ:NEO) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.05) by...

What 6 Analyst Ratings Have To Say About N...
03/18/2024 18:00:40

Earnings Scheduled For March 15, 2024
03/15/2024 09:15:18

Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on re...

Piper Sandler Maintains Overweight on NeoG...
02/26/2024 14:52:34

Piper Sandler analyst David Westenberg maintains NeoGenomics (NASDAQ:NEO) with a Overweight and raises the price target from...

Goldman Sachs Maintains Buy Rating for Neo...
02/22/2024 17:00:34

Why International Flavors & Fragrances Sha...
02/21/2024 18:50:15

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported m...

why-is-cancer-genetics-test-focused-neogenomics-stock-trading-higher-today

Why Is Cancer Genetics Test-Focused NeoGen...
02/21/2024 16:01:23

NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith ...

Toll Brothers Posts Upbeat Earnings, Joins...
02/21/2024 15:47:27

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

why-neogenomics-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket

Why NeoGenomics Shares Are Trading Higher ...
02/21/2024 13:06:42

Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-ex...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
02/21/2024 13:06:14

Evaluating NeoGenomics: Insights From 4 Fi...
02/21/2024 12:00:25